The Herbal PDR says that Commission E approved gumweed (Grindelia camporum) for bronchosis and coughs, yet defined gumweed herb as the dried tops and leaves of Grindelia robusta Nutt. (synonym of G. camphorum), and/or Grindelia squarrosa, as was the case in KOM, suggesting that the gumweed was approved by Commission E for catarrhs of the upper respiratory tract. I have entered both the KOM and PH2 interpretations here. MAD refers to G. robusta. HHB listed all three (and G. humilis), then listed activities and chemicals without saying to which Grindelia they belong. Looks like reason enough to treat it generically.
Dosages (Gumweed) : 4–6 g gumweed or 3–6 g gumweed fluid extract (KOM; PH2); 2–4 g fluid extract (MAD); 2–3 tsp(1.8–2.1 g) herb/cup tea (MAD).
Contraindications, Interactions, and Side Effects (Gumweed) : Class 1. High doses may irritate kidney and/or stomach (AHP). “Hazards and/or side effects not recorded for proper therapeutic dosages” (PH2).
Draligus Health Disclaimer: Health Information Encyclopedia is a health encyclopedia for educational purposes, but does not provide medical - health information, medical diagnosis or medical treatment for your patients.